Lidocaine non-aqueous patch, 1.8% for pain associated with post-herpetic neuralgia
AssigneeStira Pharmaceuticals LLC
InventorsSatyanarayana VALIVETI, Surya NALLURI, Phani Prasanth TIRUMALASETTY
Life of this patent
Estimating the term…
Loading patent…
AssigneeStira Pharmaceuticals LLC
InventorsSatyanarayana VALIVETI, Surya NALLURI, Phani Prasanth TIRUMALASETTY
Estimating the term…
The present invention relates to a lidocaine non-aqueous topical patch composition comprising approximately 1.8% w/w lidocaine incorporated into a non-aqueous adhesive matrix containing high and low molecular weight polyisobutylenes, hydrogenated polybutene, styrene-isoprene-styrene block copolymer, mineral oil, isopropyl myristate, silicon dioxide, and optionally antioxidants. The formulation provides enhanced skin permeation and sustained drug release with minimal crystallization. The patch is manufactured using a solvent-coating process with toluene, followed by drying and lamination to achieve desired coat weight and adhesive properties. The patch is effective for treating pain conditions such as post-herpetic neuralgia and offers improved stability, ease of application, and reduced risk of irritation.
A lidocaine non-aqueous patch, comprising:
Dependencies are inferred from the claim text.